Indivior Pharmaceuticals (INDV) Interest & Investment Income (2024 - 2026)

Indivior Pharmaceuticals' Interest & Investment Income history runs 3 years deep, the most recent figure standing at $3.0 million for Q1 2026.

• On a quarterly basis, Interest & Investment Income fell 25.0% year-over-year to $3.0 million in Q1 2026; TTM through Mar 2026 was $21.0 million, a 5.0% increase from a year earlier, with the FY2025 full-year figure at $22.0 million, down 4.35% from the prior year.
• Interest & Investment Income slipped to $3.0 million in Q1 2026 per INDV's latest filing, from $6.0 million in the prior quarter.
• Across five years, Interest & Investment Income topped out at $7.0 million in Q1 2024 and bottomed at $3.0 million in Q1 2026.
• The 3-year median for Interest & Investment Income is $6.0 million (2024), against an average of $5.3 million.
• Biggest YoY gain for Interest & Investment Income was 20.0% in 2025; the steepest drop was 42.86% in 2025.
• Year by year, Interest & Investment Income stood at $5.0 million in 2024, then gained by 20.0% to $6.0 million in 2025, then sank by 50.0% to $3.0 million in 2026.
• Per Business Quant, the three latest INDV Interest & Investment Income figures stand at $3.0 million (Q1 2026), $6.0 million (Q4 2025), and $6.0 million (Q3 2025).